Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1995-06-07
1998-07-07
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241851, 4241931, 530326, 530328, 530300, 530395, 530868, A61K 3800, C07K 14725
Patent
active
057764590
ABSTRACT:
TCR peptides from the V.beta.5 family, particularly those encompassing at least a part of the second complementarity determining region, are useful, e.g., in the diagnosis and treatment of multiple sclerosis.
REFERENCES:
patent: 4634590 (1987-01-01), Cohen et al.
patent: 4716038 (1987-12-01), Stanford et al.
patent: 4845026 (1989-07-01), Kung et al.
patent: 4873190 (1989-10-01), Saito et al.
patent: 4874845 (1989-10-01), Saito et al.
patent: 4886743 (1989-12-01), Hood et al.
patent: 5316925 (1994-05-01), Davis et al.
patent: 5340921 (1994-08-01), Brenner et al.
patent: 5612035 (1997-03-01), Howell et al.
patent: 5614192 (1997-03-01), Vandenbark
Hafler, D.A. et al., Immunology Today 17(4):152-159 (Apr., 1996), "TCR usage in human and experimental demyelinating disease".
Kumar, V et al., PNAS 87:1337-1341, Amino acid variations at a single residue in an autoimmune peptide profoundly affect is properties: T-cell activation, major histcompatibility complex binding, and ability to block experimental allergic encephalomyelit, Feb. 1990.
Hood, L. et al., PNAS 88:6899 "Clarification and retraction". Aug. 1, 1991.
Chothia, C. et al., EMBO J. 7:3745-3755, "The outline structure of the T-cell alpha-beta receptor", 1988.
Robinson, M. A. et al., pp. 269-287 in T cell Receptors (John I. Bell et al., eds), Oxford Univ. Press, Oxford, UK 1995.
Acha-Orbea et al., "Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis specific immune intervention", Cell 54:263-273 (1988).
Acha-Orbea et al., "T Cell Receptors in Murine Autoimmune Diseases", Ann. Rev. Immunol. 7:371-405 (1989).
Allegretta et al., "T Cells Responsive to Myelin Basic Protein in Patients with Multiple Sclerosis", Science 247:718-721 (1990).
Alvord et al., Exp. Allergic Encephalomyelitis, A.R. Liss Publisher, New York, pp. 523-537 (1984).
Barth et al., "The Murine T-Cell Receptor Uses A Limited Repertoire of Expressed V .beta.Gene Segments", Nature 316:517-523 (1985).
Beall et al., J. Neuroimmunol. 21:59-66 (1989).
Ben-Nun et al., "Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein", Nature 292:60-61 (1981).
Ben-Nun et al., "The Rapid Isolation of Clonable Antigen-Specific T Lymphocyte Lines Capable of Mediating Autoimmune Encephalomyelitis", European Journal of Immunology 11:195-199 (1981).
Berzofsky, "T-Cell Activation by Antigen: Promising Clues to Reception Genes and Molecules", Immunology Today 4:299-301 (1983).
Bourdette et al., "Immunity to TCR Peptides in Multiple Sclerosis", Amer. Assoc. of Immunol. pp. 2510-2519 (1994).
Bourdette et al., J. Neuroimmunol. 26:81-85 (1990).
Bourdette et al., "Basic Protein-Specific T-Cell Lines That Induce Experimental Autoimmune Encephalomyelitis in SLJ/J Mice: Comparison with Lewis Rat Lines", Cell. Immunol. 112:351-363 (1988).
Bourdette et al., "Immunity to TCR Peptides in Multiple Sclerosis I. Successful Immunization of Patients With Synthetic V.beta.5.2 and V.beta.6.1 CDR2 Peptides", J. Immunol. 152:2510-2519 (1994).
Brostoff et al., "Vaccination with T-cell receptor peptides", Immunol. Ser. 59:203-218 (1993).
Brostoff et al., J. Neuroimmunol. 13:233-240 (1986).
Burns et al., "Both Rat and Mouse T Cell Receptors Specific for the Encephalitogenic Determinant of Myelin Basic Protein Use Similar V.alpha. and V.beta.Chain Genes Even Though the Major Histocompatibility Complex and Encephalitogenic Determinants Being Recognized are Different", J. Exp. Med. 169:27-39 (1989).
Chluba et al., "T cell receptor .beta. chain usage in myelin basic protein-specific rat T-lymphocytes", Europ. J. Immunol. 19:279-284 (1989).
Chou et al., "Immunity to TCR Peptides in Multiple Sclerosis", J. Immunol. 152:2520-2529 (1994).
Chou et al., J. of Neurochem. 28:115-119 (1977).
Chou et al., "Selection of Encephalitogenic Rat T Lymphocyte Clones Recognizing and Immunodominant Epitope on Myelin Basic Protein", J. Neurosci. Res. 22:181-187 (1989).
Chou et al., J. Neurosci. Res. 23:207-216 (1989).
Clark et al., "Identification of a Diversity Segment of Human T-Cell Receptor .beta.-Chain, and Comparison with the Analogous Murine Element", Nature 311:387-389 (1984).
Claverie et al., "Implications of a Fab-Like Structure for the T-Cell Receptor", Immunol. Today 10:10-14 (1989).
Clevers et al., "The T-Cell Receptor/CD3 Complex: A Dynamic Protein Ensemble", Annual Review of Immunology 6:629-662 (1988).
Cohen, "Regulation of Autoimmune Disease Physiological and Therapeutic", Immunol. Rev. 94:5-21 (1986).
Cohen, Hosp. Prac. pp. 57-64 (1989).
Cohen et al., Cell Imm. 108:203-213 (1987).
Cohen, Prog. Immunol. VI:491-499 (1986).
Cohen and Weiner, "T-Cell Vaccination", Immunology Today9:332-335 (1988).
Desquenne-Clark et al., "T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyeleitis", Proc. Natl. Acad. Sci. USA 88:7219-7233 (1991).
Esch et al., "Observations, Legends and Conjectures Concerning Restricted T-Cell Receptor Usage and Autoimmune Disease", Critical Reviews in Immunology 11(5):249-264 (1992).
Eylar et al., "Basic A1 Protein of the Myelin Membrane", J. Biol. Chem. 246(18):5770-5784 (1971).
Ford et al., Cell. Immunol. 79:334-344 (1983).
Gammon et al., Immunol. Rev. 98:53-73 (1987).
Gascoigne et al., "Secretion of a Chimeric T-Cell Receptor-Immunoglobulin Protein", Proc. Natl. Acad. Sci. USA 84:2936-2940 (1987).
Gaur et al., "Requirement for DC8+ Cells in T Cell Receptor Peptide-Induced Clonal Unresponsiveness", Science 259:91-93 (1993).
Geha, Clin. Immunol. and Immunopath. 19:196-205 (1981).
Hafler et al., J. Immunol. 139(1):68-72 (1987).
Happ et al., J. Neuroimmunol. 19:191-204 (1988).
Hashim et al., "Suppression of autoimmunity by antibodies against synthetic T cell receptor peptides", FASEB Journal 4(7):A2023 (1990).
Hashim et al., "Biological Activity of Region 65-102 of the Myelin Basic Protein", J. Neurosci. Res. 24:222-230 (1989).
Hashim et al., J. Immunol. 144(12):4621-4627 (1990).
Herber-Katz et al., "The V-region disease hypothesis: evidence from autoimmune encephalomyleitis", Immunol. Today 10:164-169 (1989).
Heber-Katz et al., "Clonal Modulation of Experimental Allergic Encephalomyelitis by a Monoclonal Antibody Directed to the T-Cell Receptor", Advances in Neuroimmunology 540:576-577 (1988).
Higgins et al., J. Immunol. 140(2):440-445 (1988).
Holoshitz et al., "Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymohocyte lines directed against diverse antigenic determinants if myelin basic protein. Vaccination is determinant specific", J. Immunol. 131:2810-2813 (1983).
Howell et al., "Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides", Science 246:688-670 (1989).
Janeway, Nature 341:482-483 (1989).
Kappler et al., Science 244:811-813 (1989).
Kappler et al., "Self-Tolerance Eliminates T Cells Specific for MIs-Modified Products oft the Major Histocompatibility Complex", Nature 332:35-40 (1988).
Kappler et al., "A T Cell receptor V.sub.beta segment that imparts reactivity to a class II major histocompatibility complex product", Cell 49:263-271 (1987).
Karpus et al., "CD4+ Suppressor Cells of Autoimmune Encephalomyelitis Respond to T Cell Receptor-Associated Determinants of Effector Cells by Interleukin-4 Secretion", Eur. J. Immunol. 22:1757-1763 (1992).
Kitzin et al., "Preferential T-cell receptor beta-chain variable gene uise in myelin basic protein reactive T-cell clones from patients with multiple sclerosis," Proc. Natl. Acad. Sci. USA 88:9161-9165 (1991).
Kotzin et al., "Preferential T-Cell Receptor .beta.-Chain Variable Gene Use in Myelin Basic Protein-Reactive T-Cell Clones From Patients With Multiple Sclerosis," Proc. Natl. Acad. Sci. USA 88:9161-9165 (1991).
Kumar et al., "The Involvement of T Cell Receptor Peptide-Specific Regulatory CD4+ T Cells in Recovery From Antigen-Induced Autoimmune Disease," J. Exp. Med. 178:909-916 (1993).
Kumar et al., Ann. Rev. Immunol. 7:657-682 (1989).
Lider et al., J. Autoimmun. 2:87-99 (1989).
Lider et al., "Anti-Idiotypic Network Induced by T Cell Vaccination Again
Connetics Corporation
Cunningham Thomas M.
Lowin, Esq. David A.
LandOfFree
TCR V beta 5 peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TCR V beta 5 peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TCR V beta 5 peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1202580